102 related articles for article (PubMed ID: 7279697)
21. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
22. [Pancreatic carcinoma in chronic pancreatitis with inflammatory tumor of the head of the pancreas].
Schlosser W; Schoenberg MH; Rhein E; Siech M; Gansauge F; Beger HG
Z Gastroenterol; 1996 Jan; 34(1):3-8. PubMed ID: 8776168
[TBL] [Abstract][Full Text] [Related]
23. [Concentration of serum carcinoembryonic antigen in diseases of the pancreas].
Libman E; Glisić L; Lemberger J; Novaković R; Simić P
Med Pregl; 1979; 32(7-8):309-12. PubMed ID: 522828
[No Abstract] [Full Text] [Related]
24. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
25. Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma.
Kuroki T; Tomioka T; Tajima Y; Inoue K; Ikematsu Y; Ichinose K; Furui J; Kanematsu T
Br J Cancer; 1999 Sep; 81(2):350-3. PubMed ID: 10496364
[TBL] [Abstract][Full Text] [Related]
26. Serum angiotensin converting enzyme levels in pancreatic diseases.
Ibiş M; Yüksel O; Yilmaz G; Köklü S; Yilmaz FM; Ertuğrul I; Uçar E; Altiparmak ME
Hepatogastroenterology; 2008; 55(86-87):1814-7. PubMed ID: 19102399
[TBL] [Abstract][Full Text] [Related]
27. [Clinical evaluation of a pancreatic oncofetal antigen (POA) in carcinoma of the pancreas].
Hishinuma S; Takami H; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Miyoshi K; Ishii T; Yamamori S
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1432-7. PubMed ID: 6097615
[No Abstract] [Full Text] [Related]
28. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
29. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
30. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody.
Hosoda H; Okawa-Takatsuji M; Shinmura W; Hasimoto N; Ozaki Y; Ikeda Y
Pancreas; 2008 Jul; 37(1):e1-7. PubMed ID: 18580434
[TBL] [Abstract][Full Text] [Related]
31. Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera.
Zhao J; Patwa TH; Qiu W; Shedden K; Hinderer R; Misek DE; Anderson MA; Simeone DM; Lubman DM
J Proteome Res; 2007 May; 6(5):1864-74. PubMed ID: 17428079
[TBL] [Abstract][Full Text] [Related]
32. ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.
Standop J; Schneider M; Ulrich A; Mathiak G; Brand RE; Buechler MW; Pour PM
Oncol Rep; 2004 Dec; 12(6):1309-15. PubMed ID: 15547756
[TBL] [Abstract][Full Text] [Related]
33. Serum prostate-specific antigen in pancreatic disease.
Pezzilli R; Bertaccini A; Billi P; Zanarini L; Miglio F; Martorana G
Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):580-3. PubMed ID: 10604096
[TBL] [Abstract][Full Text] [Related]
34. Circulating immune complexes in carcinoma of the pancreas.
Mihas AA; Volanakis JE; Schrohenloher RE; Mihas TA
Anticancer Res; 1981; 1(3):155-8. PubMed ID: 7342854
[TBL] [Abstract][Full Text] [Related]
35. Expression of C-242 antigen in pancreatic ductal adenocarcinoma.
Mäkinen K; Eskelinen M; Lipponen P; Alhava E
Anticancer Res; 1995; 15(4):1605-8. PubMed ID: 7654056
[TBL] [Abstract][Full Text] [Related]
36. [Immunologic mechanisms in pancreatic diseases].
Velbri S; Nutt H; Kasesalu G
Z Gesamte Inn Med; 1973 Apr; 28(8):222-7. PubMed ID: 4716919
[No Abstract] [Full Text] [Related]
37. Pancreatic oncofetal antigen in the detection of experimental cancer of the pancreas.
Johnson FE; Laregina MC; Gelder FB
Tumour Biol; 1985; 6(1):37-40. PubMed ID: 4023561
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic oncofetal antigen in pancreatic juices. Partial chemical characterization and diagnostic application of a pancreatic cancer-associated antigen.
Schmiegel WH; Becker WM; Arndt R; Hamann A; Soehendra N; Jessen K; Classen M; Thiele HG
Scand J Gastroenterol; 1981; 16(8):1033-39. PubMed ID: 7336130
[TBL] [Abstract][Full Text] [Related]
39. Is zinc concentration in pancreatic fluid a marker for pancreatic diseases?
Pungpapong S; Scolapio JS; Woodward TA; Wallace MB; Raimondo M
JOP; 2005 Sep; 6(5):425-30. PubMed ID: 16186663
[TBL] [Abstract][Full Text] [Related]
40. [Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].
Markocka-Maczka K
Wiad Lek; 2003; 56(11-12):537-40. PubMed ID: 15058160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
